Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Dose Study of Phentolamine Mesylate Eye Drops in Patients With Severe Night Vision Disturbances

NCT04004507 is registered in ClinicalTrials.gov with Ocuphire Pharma, Inc. as lead sponsor.

NCT NCT04004507
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04004507 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Dose Study of Phentolamine Mesylate Eye Drops in Patients With Severe Night Vision Disturbances
Lead sponsor
Ocuphire Pharma, Inc.
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2007
Completion date
February 29, 2008
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

decrease in night vision, disturbance; vision, loss